Search Results

Researchers at Children’s Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania revealed a powerful new bone marrow atlas that will offer the public a first-of-its-kind visual passport into the spectrum of healthy and diseased blood production.

Cimeio Therapeutics today announced a preclinical research collaboration with Saar Gill, M.D., Ph.D., an associate professor of medicine and a researcher in the Center for Cellular Immunotherapies in the Perelman School of Medicine at the University of Pennsylvania, to research and evaluate a novel universal immunotherapy with potential to treat multiple blood and bone marrow cancers.

Brain–computer interface company Precision Neuroscience Corporation announced the launch of two new clinical study sites, at Mount Sinai Health System and Perelman School of Medicine at the University of Pennsylvania.

Asensus Surgical, Inc. announced that St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan has entered into an agreement to lease and utilize a Senhance® Surgical System in the Urology and Gastroenterology/General Surgery department.

Charles River Laboratories International, Inc. (NYSE: CRL) and National University of Singapore’s (NUS) Yong Loo Lin School of Medicine (NUS Medicine),

Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Raul Torres’s Lab at the University of Colorado School of Medicine.

Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen’s Lab at Emory University School of Medicine.

Curiox Biosystems is pleased to announce its collaboration with Dr. Marco Ruella, an Assistant Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn), to support efforts in the development of next-generation cancer cell therapies.

The Feinstein Institutes for Medical Research congratulates two scientists from the University of Pennsylvania Perelman School of Medicine, Katalin Karikó, PhD, and Drew Weissman, MD, PhD, for being awarded the 2023 Nobel Prize in Physiology or Medicine for their groundbreaking messenger RNA research that helped develop mRNA-based coronavirus disease 2019 vaccines.